Vaxart Inc (VXRT)

$0.32 0.00 (N/A)
Market Cap 97.49M
Revenue (ttm) 28.70M
Net Income (ttm) -66.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -233.28%
Debt to Equity Ratio 0.00
Volume 11,568,300
Avg Vol 5,416,006
Day's Range N/A - N/A
Shares Out 228.31M
Stochastic %K 7%
Beta 1.14
Analysts Strong Sell
Price Target $4.67

Company Profile

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment of SARS-CoV-1, SARS-CoV-2, and Middle East respiratory syndrome...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 550 3500
Fax: 650 871 8580
Website: vaxart.com
Address:
170 Harbor Way, Suite 300, South San Francisco, United States
ralm9
ralm9 May. 13 at 9:41 PM
$VXRT something is dropping tomorrow
2 · Reply
YetAnotherInvestor
YetAnotherInvestor May. 13 at 9:20 PM
$VXRT typed " why has vaxart not sent the annual proxies yet - it seems very delayed - can you generate hypothesis on why they are delaying so much" on chatgpt....
1 · Reply
Vaxy_Tim
Vaxy_Tim May. 13 at 9:10 PM
$VXRT Is Anyone here in DXYZ for the pre IPO spacex and anthropic?
0 · Reply
Tycho11261
Tycho11261 May. 13 at 8:15 PM
$VXRT closed on the HOD🤘🤘🤘
0 · Reply
Joe_Mussia
Joe_Mussia May. 13 at 7:39 PM
$VXRT Yes, Alex, I'll take "This didn't have to happen" for $1000, please
0 · Reply
Nik_CA
Nik_CA May. 13 at 7:38 PM
$VXRT Not exactly apples to apples comparison but still wondering if there's any effort from BOD to get FDA approval after P2B like the one below "The FDA has approved oral decitabine/cedazuridine plus venetoclax for newly diagnosed AML unfit for intensive chemo, based on phase 2 ASCERTAIN-V data." https://www.onclive.com/view/fda-approves-decitabine-cedazuridine-plus-venetoclax-in-newly-diagnosed-aml?utm_medium=email&_hsenc=p2ANqtz-_UOPqscrpoMRpz_AOnk_r5M4Q682mYCF9ZxxdkzpsBAe3lRMDW1rSOGdDYqwnvTTlES1i2Pfd-NJtTBXqP6KlT1vNU2g&_hsmi=418652475&utm_content=418652475&utm_source=hs_email
2 · Reply
vigi
vigi May. 13 at 7:30 PM
$VXRT cat to human bird flu confirmed (what took so long) come on jr. https://www.avma.org/news/cdc-confirms-cat-human-transmission-avian-influenza
0 · Reply
How2TieAKnot
How2TieAKnot May. 13 at 7:20 PM
$VXRT About Baric on LI Perhaps some of the skuttle butt needs to be looked at again. https://www.linkedin.com/posts/juanlama_science-sarscov2-wuhan-share-7460356791340539904-IJ3N?utm_source=share&utm_medium=member_desktop&rcm=ACoAABGUdNEB_4ImCT-fSrqFY6LDymkUnsntrn4
2 · Reply
PatrickKane88
PatrickKane88 May. 13 at 7:08 PM
$VXRT BRETT GIROIR is the CEO OF ALTESA folks Reuters reported on Friday that former FDA Commissioner Steve Hahn and ​former acting commissioner and Assistant Health Secretary Brett Giroir were under consideration for the ⁠permanent job, among others.
2 · Reply
PatrickKane88
PatrickKane88 May. 13 at 7:06 PM
Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms | Reuters $VXRT https://www.reuters.com/legal/transactional/makary-exit-may-temporarily-lift-biotech-sentiment-fda-leadership-vacuum-looms-2026-05-13/
0 · Reply
Latest News on VXRT
No data available.
ralm9
ralm9 May. 13 at 9:41 PM
$VXRT something is dropping tomorrow
2 · Reply
YetAnotherInvestor
YetAnotherInvestor May. 13 at 9:20 PM
$VXRT typed " why has vaxart not sent the annual proxies yet - it seems very delayed - can you generate hypothesis on why they are delaying so much" on chatgpt....
1 · Reply
Vaxy_Tim
Vaxy_Tim May. 13 at 9:10 PM
$VXRT Is Anyone here in DXYZ for the pre IPO spacex and anthropic?
0 · Reply
Tycho11261
Tycho11261 May. 13 at 8:15 PM
$VXRT closed on the HOD🤘🤘🤘
0 · Reply
Joe_Mussia
Joe_Mussia May. 13 at 7:39 PM
$VXRT Yes, Alex, I'll take "This didn't have to happen" for $1000, please
0 · Reply
Nik_CA
Nik_CA May. 13 at 7:38 PM
$VXRT Not exactly apples to apples comparison but still wondering if there's any effort from BOD to get FDA approval after P2B like the one below "The FDA has approved oral decitabine/cedazuridine plus venetoclax for newly diagnosed AML unfit for intensive chemo, based on phase 2 ASCERTAIN-V data." https://www.onclive.com/view/fda-approves-decitabine-cedazuridine-plus-venetoclax-in-newly-diagnosed-aml?utm_medium=email&_hsenc=p2ANqtz-_UOPqscrpoMRpz_AOnk_r5M4Q682mYCF9ZxxdkzpsBAe3lRMDW1rSOGdDYqwnvTTlES1i2Pfd-NJtTBXqP6KlT1vNU2g&_hsmi=418652475&utm_content=418652475&utm_source=hs_email
2 · Reply
vigi
vigi May. 13 at 7:30 PM
$VXRT cat to human bird flu confirmed (what took so long) come on jr. https://www.avma.org/news/cdc-confirms-cat-human-transmission-avian-influenza
0 · Reply
How2TieAKnot
How2TieAKnot May. 13 at 7:20 PM
$VXRT About Baric on LI Perhaps some of the skuttle butt needs to be looked at again. https://www.linkedin.com/posts/juanlama_science-sarscov2-wuhan-share-7460356791340539904-IJ3N?utm_source=share&utm_medium=member_desktop&rcm=ACoAABGUdNEB_4ImCT-fSrqFY6LDymkUnsntrn4
2 · Reply
PatrickKane88
PatrickKane88 May. 13 at 7:08 PM
$VXRT BRETT GIROIR is the CEO OF ALTESA folks Reuters reported on Friday that former FDA Commissioner Steve Hahn and ​former acting commissioner and Assistant Health Secretary Brett Giroir were under consideration for the ⁠permanent job, among others.
2 · Reply
PatrickKane88
PatrickKane88 May. 13 at 7:06 PM
Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms | Reuters $VXRT https://www.reuters.com/legal/transactional/makary-exit-may-temporarily-lift-biotech-sentiment-fda-leadership-vacuum-looms-2026-05-13/
0 · Reply
SpiritedTwit
SpiritedTwit May. 13 at 7:04 PM
$VXRT why wouldn't one of these cruise ship companies just fund our noro virus pill? Probably because they have zero understanding of its existence...... Or maybe they are waiting for our "2C" to finish *This statement is inundated with sarcasm
1 · Reply
PatrickKane88
PatrickKane88 May. 13 at 6:59 PM
Does Vaxart Hold the Key to the Elusive Norovirus Vaccine? - BioSpace $VXRT https://www.biospace.com/drug-development/does-vaxart-hold-the-key-to-the-elusive-norovirus-vaccine
0 · Reply
PatrickKane88
PatrickKane88 May. 13 at 6:58 PM
$VXRT Current Status and Future Plans Vaxart plans to advance its clinical trials, with a Phase 3 trial expected to begin soon, contingent on securing necessary partnerships or funding. The company is focused on demonstrating the vaccine's efficacy and safety to meet the urgent need for a norovirus vaccine, given the virus's widespread impact on public health.
1 · Reply
Tycho11261
Tycho11261 May. 13 at 6:54 PM
$VXRT let's bounce above .70 and see some action! Nodes are locked and loaded, yeah?🤘
0 · Reply
PatrickKane88
PatrickKane88 May. 13 at 6:49 PM
$VXRT Norovirus is one of the leading causes of gastrointestinal infections worldwide. Now, an oral vaccine has managed to generate strong immune responses in the mucosa and even reduce the spread of the virus in vaccinated volunteers. These are the results of a phase 2 clinical trial promoted by Vaxart, the Cincinnati Children's Hospital Medical Center and the universities of Stanford University, the University of Maryland Baltimore and Harvard University. The details are published in the journal Science Translational Medicine. "The promising evidence of vaccine effectiveness supports its potential to address the lack of safe and reliable vaccines against norovirus, one of the main causes of gastrointestinal infections worldwide," the publication describes.
0 · Reply
PatrickKane88
PatrickKane88 May. 13 at 6:47 PM
$VXRT https://www.lafm.com.co/internacional/norovirus-sintomas-contagio-vacuna-investigacion-salud-399195
0 · Reply
GoGreenForMe
GoGreenForMe May. 13 at 6:39 PM
$VXRT
1 · Reply
How2TieAKnot
How2TieAKnot May. 13 at 6:33 PM
$VXRT Columbia International news... page in Spanish/English https://www.lafm.com.co/internacional/norovirus-sintomas-contagio-vacuna-investigacion-salud-399195 Mentions us and is about the latest Noro outbreak of 1700 SNIP: Norovirus is a leading cause of gastrointestinal infections worldwide. Now, an oral vaccine has successfully generated strong mucosal immune responses and even reduced viral shedding in vaccinated volunteers. These are the results of a phase 2 clinical trial conducted by Vaxart, Cincinnati Children's Hospital Medical Center, and Stanford University, the University of Maryland Baltimore, and Harvard University. The details are published in the journal Science Translational Medicine. “The promising signs of vaccine efficacy support its potential to address the lack of safe and reliable vaccines against norovirus, a leading cause of gastrointestinal infections worldwide,” the publication describes.
4 · Reply
Myturn
Myturn May. 13 at 6:13 PM
$VXRT Short Interest went down again — now below 3 million shares, possibly the lowest level seen in the current decade! This is a positive sign. Shorts continue to slowly cover their positions in Vaxart. But why so slowly? Apparently, they also know that the Vaxart management team executes on almost everything very slowly 😢😢😢 Unfortunately, the market seems to believe that too.
2 · Reply
Terry_CA3
Terry_CA3 May. 13 at 5:37 PM
$VXRT RDW
1 · Reply
Garza759ify_YF
Garza759ify_YF May. 13 at 5:13 PM
$VXRT
0 · Reply
7xbagger
7xbagger May. 13 at 5:09 PM
$VXRT . some day I will have AI analyze the data and show me the patterns and guilt of collusion. I want to harvest many tickers to show a general theft by organized crime.. yes brokers can be considered criminals organizing if they coordinate spoofing activities..
0 · Reply